Approvals/TGA/DUPIXENT dupilumab 200 mg (175 mg/mL) solution for injection pre-filled syringe with needle shield

Approved

STANDARD

DUPIXENT dupilumab 200 mg (175 mg/mL) solution for injection pre-filled syringe with needle shield

Sanofi-Aventis Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: bd1b9e9648c346db
Product Name: DUPIXENT dupilumab 200 mg (175 mg/mL) solution for injection pre-filled syringe with needle shield
Artg Id: 302463
Artg Name: DUPIXENT dupilumab 200 mg (175 mg/mL) solution for injection pre-filled syringe with needle shield
Sponsor: Sanofi-Aventis Australia Pty Ltd
Company Detail Path: /organization/sanofi-aventis-australia-pty-ltd
Artg Date: 2019-05-28
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/30fd823fe34d32cf01f3171c22464510.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/ffdf4d845b4cf3bb2db817e2109e341f.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

bd1b9e9648c346db

Type

Standard